Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093968384> ?p ?o ?g. }
- W2093968384 endingPage "32" @default.
- W2093968384 startingPage "26" @default.
- W2093968384 abstract "Objectives: To retrospectively evaluate the efficacy and tolerability of 5-fluorouracil and low-dose cisplatin (FP)-based preoperative concurrent chemoradiotherapy (PCRT) and gemcitabine (GEM)-based PCRT in patients with potentially resectable pancreatic cancer. Methods: Between December 2000 and December 2004, 32 patients with potentially resectable pancreatic cancer were treated with PCRT. All patients received external beam radiotherapy (total dose of 40 Gy) for 4 weeks. Concurrently, chemotherapy was performed intravenously with continuous 5-fluorouracil 200 mg/m2/d and intermittent cisplatin bolus 3 to 6 mg/m2/d for 4 weeks (Arm FP-PCRT, n = 14) or weekly GEM 400 mg/m2 for 3 weeks (Arm GEM-PCRT, n = 18). The patients were restaged 3 to 4 weeks after the end of PCRT and explored for resection in cases without distant metastases. Results: The 3-year survival rates and median survival were 29.4% and 20.5 months for the resected patients (n = 24) and 0% and 5.5 months for unresected patients (n = 8), respectively (P < 0.0001). The 1-, 2-, 3-year survival rates and median survival were 87.5%, 62.5%, 33.3%, and 26 months for the resected patients treated with FP-PCRT and 75%, 40%, 26.7%, and 19.9 months for the resected patients treated with GEM-PCRT (respectively; P = not significant). Most of the toxicities of both regimens were slight and were in grade1 to 2. Grade 1 to 3 leukopenia (43% vs 100%) and thrombocytopenia (0% vs 39%) were significantly different between the FP-PCRT and GEM-PCRT patients. Conclusions: The PCRT regimens in this article enabled selection of 24 of 32 patients for surgery and resulted in encouraging survival results and acceptable toxicities." @default.
- W2093968384 created "2016-06-24" @default.
- W2093968384 creator A5028936803 @default.
- W2093968384 creator A5042466993 @default.
- W2093968384 creator A5043484565 @default.
- W2093968384 creator A5044552280 @default.
- W2093968384 creator A5046527850 @default.
- W2093968384 creator A5053989482 @default.
- W2093968384 creator A5054612416 @default.
- W2093968384 creator A5071192697 @default.
- W2093968384 creator A5075713045 @default.
- W2093968384 creator A5079700817 @default.
- W2093968384 date "2008-01-01" @default.
- W2093968384 modified "2023-10-14" @default.
- W2093968384 title "Neoadjuvant Chemoradiation in Patients With Potentially Resectable Pancreatic Cancer" @default.
- W2093968384 cites W1548210045 @default.
- W2093968384 cites W1849267981 @default.
- W2093968384 cites W1892409143 @default.
- W2093968384 cites W1930757563 @default.
- W2093968384 cites W1931508686 @default.
- W2093968384 cites W1954948139 @default.
- W2093968384 cites W1972197563 @default.
- W2093968384 cites W1972373303 @default.
- W2093968384 cites W1975996978 @default.
- W2093968384 cites W1980888712 @default.
- W2093968384 cites W1994461500 @default.
- W2093968384 cites W2016236483 @default.
- W2093968384 cites W2029243506 @default.
- W2093968384 cites W2036409540 @default.
- W2093968384 cites W2048149859 @default.
- W2093968384 cites W2061274398 @default.
- W2093968384 cites W2073810602 @default.
- W2093968384 cites W2080202323 @default.
- W2093968384 cites W2090721857 @default.
- W2093968384 cites W2103607678 @default.
- W2093968384 cites W2115661389 @default.
- W2093968384 cites W2156302506 @default.
- W2093968384 cites W2179136111 @default.
- W2093968384 cites W2260988755 @default.
- W2093968384 cites W2285738680 @default.
- W2093968384 cites W2340730724 @default.
- W2093968384 cites W2409110012 @default.
- W2093968384 cites W4253769310 @default.
- W2093968384 cites W4293241248 @default.
- W2093968384 doi "https://doi.org/10.1097/mpa.0b013e31814b229a" @default.
- W2093968384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18192876" @default.
- W2093968384 hasPublicationYear "2008" @default.
- W2093968384 type Work @default.
- W2093968384 sameAs 2093968384 @default.
- W2093968384 citedByCount "40" @default.
- W2093968384 countsByYear W20939683842012 @default.
- W2093968384 countsByYear W20939683842013 @default.
- W2093968384 countsByYear W20939683842014 @default.
- W2093968384 countsByYear W20939683842015 @default.
- W2093968384 countsByYear W20939683842016 @default.
- W2093968384 countsByYear W20939683842017 @default.
- W2093968384 countsByYear W20939683842018 @default.
- W2093968384 countsByYear W20939683842019 @default.
- W2093968384 countsByYear W20939683842020 @default.
- W2093968384 countsByYear W20939683842021 @default.
- W2093968384 countsByYear W20939683842022 @default.
- W2093968384 crossrefType "journal-article" @default.
- W2093968384 hasAuthorship W2093968384A5028936803 @default.
- W2093968384 hasAuthorship W2093968384A5042466993 @default.
- W2093968384 hasAuthorship W2093968384A5043484565 @default.
- W2093968384 hasAuthorship W2093968384A5044552280 @default.
- W2093968384 hasAuthorship W2093968384A5046527850 @default.
- W2093968384 hasAuthorship W2093968384A5053989482 @default.
- W2093968384 hasAuthorship W2093968384A5054612416 @default.
- W2093968384 hasAuthorship W2093968384A5071192697 @default.
- W2093968384 hasAuthorship W2093968384A5075713045 @default.
- W2093968384 hasAuthorship W2093968384A5079700817 @default.
- W2093968384 hasConcept C121608353 @default.
- W2093968384 hasConcept C126322002 @default.
- W2093968384 hasConcept C141071460 @default.
- W2093968384 hasConcept C197934379 @default.
- W2093968384 hasConcept C2776694085 @default.
- W2093968384 hasConcept C2777844706 @default.
- W2093968384 hasConcept C2778375690 @default.
- W2093968384 hasConcept C2778424827 @default.
- W2093968384 hasConcept C2780210213 @default.
- W2093968384 hasConcept C2780258809 @default.
- W2093968384 hasConcept C2780456651 @default.
- W2093968384 hasConcept C2780873365 @default.
- W2093968384 hasConcept C509974204 @default.
- W2093968384 hasConcept C71924100 @default.
- W2093968384 hasConcept C90924648 @default.
- W2093968384 hasConceptScore W2093968384C121608353 @default.
- W2093968384 hasConceptScore W2093968384C126322002 @default.
- W2093968384 hasConceptScore W2093968384C141071460 @default.
- W2093968384 hasConceptScore W2093968384C197934379 @default.
- W2093968384 hasConceptScore W2093968384C2776694085 @default.
- W2093968384 hasConceptScore W2093968384C2777844706 @default.
- W2093968384 hasConceptScore W2093968384C2778375690 @default.
- W2093968384 hasConceptScore W2093968384C2778424827 @default.
- W2093968384 hasConceptScore W2093968384C2780210213 @default.
- W2093968384 hasConceptScore W2093968384C2780258809 @default.
- W2093968384 hasConceptScore W2093968384C2780456651 @default.